Delhi High Court allows Alembic, Natco to export Bayer drug for specific purposes - ( via NewsPoints Desk)

  • The Delhi High Court has permitted Alembic Pharmaceuticals and Natco Pharma to export generic version of Bayer's cancer drug sorafenib and anticoagulant rivaroxabin for development, clinical trials and regulatory clearances, reported Wednesday.

  • “Sale, use, construction of patented products…for purposes both within the country and abroad is authorised and legal provided the seller ensures that the end use and purpose of sale/export is reasonably related to research and development of information in compliance with regulations or laws of India," the court ruled.

  • The court had previously permitted generic drug manufacturers to export patented drugs for the purposes of development, clinical trials and regulatory clearance.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.